FRM
RETA
Fox Run Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,352
| Closed | -$260K | – | 954 |
|
|
2022
Q3 | $260K | Buy |
+10,352
| New | +$260K | 0.1% | 401 |
|
|
2020
Q3 | – | Sell |
-1,452
| Closed | -$227K | – | 352 |
|
|
2020
Q2 | $227K | Sell |
1,452
-308
| -18% | -$48.2K | 0.3% | 181 |
|
|
2020
Q1 | $254K | Buy |
1,760
+507
| +40% | +$73.2K | 0.6% | 47 |
|
|
2019
Q4 | $256K | Buy |
+1,253
| New | +$256K | 0.21% | 251 |
|